There is evidence that high frequency, as well as long duration, hemod
ialysis provides better clinical outcomes. We developed nocturnal hemo
dialysis, a new innovative form of renal replacement therapy, which is
performed six to seven nights per week for 8 to 10 h during sleep at
home. Blood flow was set at 300 ml/min and dialysate flow at 100 ml/mi
n. An internal jugular catheter was used as the vascular access. Speci
al precautions were taken to prevent accidental disconnection during s
leep, as well as air embolization. Dialysis functions from the patient
's home were monitored continuously via a modem at the nocturnal hemod
ialysis center. Twelve patients have completed training and have been
successfully performing nocturnal hemodialysis for up to 34 mo. This s
tudy represents 170 patient months of experience accumulated over 3 yr
. There was hemodynamic stability and significant subjective improveme
nt in patient well being. Nightly Kt/V was 0.99. Weekly removal of pho
sphate was twice as high and beta(2) microglobulin 4 times as high as
conventional hemodialysis. All patients have discontinued their phosph
ate binders and have increased dietary phosphate and protein intake. B
P control was achieved with fewer medications. Dialyzer reuse has decr
eased the operating costs to the level of the other form of home dialy
sis. Complications were infrequent and were related primarily to the d
ialysis access. Nocturnal hemodialysis represents the most efficient f
orm of dialysis at low cost and should be considered as an option for
patients who can be trained for home hemodialysis.